statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Commit To Buy CorMedix At $3, Earn 21.6% Annualized Using Options

Investors considering a purchase of CorMedix Inc (CRMD) shares, but cautious about paying the going market price of 4.31/share, might benefit from considering selling puts among the alternative...

CorMedix Inc. to Present at the Needham Annual Healthcare Conference

BERKELEY HEIGHTS, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...

CorMedix (CRMD, $3.81) RSI Indicator left the overbought zone on March 15, 2024

This is a signal that CRMD's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

CorMedix Inc. (NASDAQ:CRMD) CEO Joseph Todisco Purchases 13,561 Shares

CorMedix Inc. (NASDAQ:CRMD  Get Free Report) CEO Joseph Todisco acquired 13,561 shares of the firms stock in a transaction that occurred on Wednesday, March 13th. The stock was...

CorMedix (CRMD, $3.9) price may drop as it broke higher Bollinger Band on Mar 13, 2024

This price move could be a signal that CRMD may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

CorMedix CEO buys 13,561 shares at $3.74

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Q4 2023 CorMedix Inc Earnings Call Transcript

Cormedix Inc (CRMD) Reports Increased Operating Expenses Amid Pre-Launch Activities for DefenCath

Net Loss Widens in Q4 and Full Year 2023; Company Prepares for Commercial LaunchRelated Stocks: CRMD...

CorMedix expects cash to fund operations for at least 12 months

CorMedix reports Q4 EPS (26c), consensus (20c)

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

Volume	357,577.00
52-Wk High	$7.00
52-Wk Low	$2.57

CRMD CorMedix Inc

About

Feed

News

Sentiment

Earnings

Fundamentals